Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis

D Chaudhuri, K Sasaki, A Karkar, S Sharif… - Intensive care …, 2021 - Springer
Purpose Corticosteroids are now recommended for patients with severe COVID-19 including
those with COVID-related ARDS. This has generated renewed interest regarding whether …

The history and mystery of alveolar epithelial type II cells: focus on their physiologic and pathologic role in lung

B Ruaro, F Salton, L Braga, B Wade… - International journal of …, 2021 - mdpi.com
Alveolar type II (ATII) cells are a key structure of the distal lung epithelium, where they exert
their innate immune response and serve as progenitors of alveolar type I (ATI) cells …

Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia

GU Meduri, MC Shih, L Bridges, TJ Martin… - Intensive care …, 2022 - Springer
Purpose Severe community-acquired pneumonia (CAP) requiring intensive care unit
admission is associated with significant acute and long-term morbidity and mortality. We …

Different methods to improve the monitoring of noninvasive respiratory support of patients with severe pneumonia/ARDS due to COVID-19: an update

P Pelosi, R Tonelli, C Torregiani, E Baratella… - Journal of Clinical …, 2022 - mdpi.com
The latest guidelines for the hospital care of patients affected by coronavirus disease 2019
(COVID-19)-related acute respiratory failure have moved towards the widely accepted use of …

Cytokine profiles as potential prognostic and therapeutic markers in SARS-CoV-2-induced ARDS

F Salton, P Confalonieri, G Campisciano… - Journal of clinical …, 2022 - mdpi.com
Background. Glucocorticoids (GCs) have been shown to reduce mortality and the need for
invasive mechanical ventilation (IMV) in SARS-CoV-2-induced acute respiratory distress …

Interstitial lung disease at high resolution CT after SARS-CoV-2-related acute respiratory distress syndrome according to pulmonary segmental anatomy

E Baratella, B Ruaro, C Marrocchio… - Journal of Clinical …, 2021 - mdpi.com
Background: The purpose of this study was to evaluate High-Resolution CT (HRCT) findings
in SARS-CoV-2-related ARDS survivors treated with prolonged low-dose …

[HTML][HTML] Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)

F Salton, P Confalonieri, S Centanni… - European …, 2023 - Eur Respiratory Soc
Background Dysregulated systemic inflammation is the primary driver of mortality in severe
coronavirus disease 2019 (COVID-19) pneumonia. Current guidelines favour a 7–10-day …

[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и аутоиммунитет

ЕЛ Насонов - Научно-практическая ревматология, 2021 - cyberleninka.ru
Пандемия коронавирусной болезни 2019 (coronavirus disease, COVID-19),
этиологически связанной с вирусом SARS-CoV-2 (severe acute respiratory syndrome …

Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

A Torres, A Motos, C Cillóniz, A Ceccato… - Intensive care …, 2022 - Springer
Purpose Although there is evidence supporting the benefits of corticosteroids in patients
affected with severe coronavirus disease 2019 (COVID-19), there is little information related …

[HTML][HTML] Efficacy and safety of corticosteroids for the treatment of community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled …

HA Cheema, A Musheer, A Ejaz, AA Paracha… - Journal of critical …, 2024 - Elsevier
Background The role of corticosteroids in the treatment of community-acquired pneumonia
(CAP) remains uncertain. We conducted an updated meta-analysis to investigate the …